Cargando…
Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer
Breast cancer (BC) is a heterogeneous disease characterized by different biopathological features, differential response to therapy and substantial variability in long-term-survival. BC heterogeneity recapitulates genetic and epigenetic alterations affecting transformed cell behavior. The estrogen r...
Autores principales: | Salvati, Annamaria, Gigantino, Valerio, Nassa, Giovanni, Mirici Cappa, Valeria, Ventola, Giovanna Maria, Cracas, Daniela Georgia Cristina, Mastrocinque, Raffaella, Rizzo, Francesca, Tarallo, Roberta, Weisz, Alessandro, Giurato, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312026/ https://www.ncbi.nlm.nih.gov/pubmed/32517194 http://dx.doi.org/10.3390/ijms21114068 |
Ejemplares similares
-
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells
por: Salvati, Annamaria, et al.
Publicado: (2019) -
The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei
por: Nassa, Giovanni, et al.
Publicado: (2019) -
WIND (Workflow for pIRNAs aNd beyonD): a strategy for in-depth analysis of small RNA-seq data
por: Geles, Konstantinos, et al.
Publicado: (2021) -
Quantitative mapping of RNA-mediated nuclear estrogen receptor β interactome in human breast cancer cells
por: Giurato, Giorgio, et al.
Publicado: (2018) -
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer
por: Salvati, Annamaria, et al.
Publicado: (2022)